ORLANDO IMMUNOLOGY CENTER
🇺🇸United States
Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)A Pharmacist-run PrEP Program for Women
Terminated
- Conditions
- HIV Prevention
- Interventions
- Drug: LA-CABDrug: TDF/FTC
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Orlando Immunology Center
- Target Recruit Count
- 2
- Registration Number
- NCT05755204
- Locations
- 🇺🇸
Orlando Immunology Center, Orlando, Florida, United States
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Orlando Immunology Center
- Target Recruit Count
- 50
- Registration Number
- NCT05220358
- Locations
- 🇺🇸
Orlando Immunology Center, Orlando, Florida, United States
Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2006-04-07
- Last Posted Date
- 2008-05-22
- Lead Sponsor
- Orlando Immunology Center
- Target Recruit Count
- 20
- Registration Number
- NCT00312169
- Locations
- 🇺🇸
Special Services Adult HIV Clinic, Fresno, California, United States
🇺🇸AltaMed Health Services Corporation, Los Angelos, California, United States
🇺🇸Shared Medical Research Foundation, Tarzana, California, United States
News
No news found